INDEMNIFICATION AGREEMENTIndemnification Agreement • November 10th, 2014 • Cohbar, Inc. • Pharmaceutical preparations • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of [date] by and between Cohbar, Inc., a Delaware corporation (the “Company”), and [Name] (“Indemnitee”).
ContractCohbar, Inc. • November 10th, 2014 • Pharmaceutical preparations • Delaware
THIS WARRANT AND THE UNDERLYING SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATE. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS IN ACCORDANCE WITH APPLICABLE REGISTRATION REQUIREMENTS OR AN EXEMPTION THEREFROM. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE ISSUER THAT SUCH OFFER, SALE, TRANSFER, PLEDGE OR HYPOTHECATION OTHERWISE COMPLIES WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS. THIS WARRANT MUST BE SURRENDERED TO THE COMPANY AS A CONDITION PRECEDENT TO THE SALE, TRANSFER, PLEDGE OR HYPOTHECATION OF ANY INTEREST IN ANY OF THE SECURITIES REPRESENTED HEREBY.
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • November 10th, 2014 • Cohbar, Inc. • Pharmaceutical preparations • California
This Exclusive License Agreement and the attached Appendix A (collectively, the “Agreement”) is made and is effective this 30th day of November 2011 (the “Effective Date”) between THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (“The Regents”), a California corporation having its corporate offices located at 1111 Franklin Street, Oakland, California 94607-5200, acting through The Office of Intellectual Property and Industry Sponsored Research of the University of California, Los Angeles, located at 11000 Kinross Avenue, Suite 200, Los Angeles, CA 90095-1406, and Albert Einstein College of Medicine of Yeshiva University, a Division of Yeshiva University, a corporation organized and existing under the laws of the State of New York, having an office and place of business at 1300 Morris Park Avenue, Bronx, New Your 10461 (“Einstein”), and COHBAR, INC. (“Licensee”), a Delaware corporation having a principal place of business at 910 Rockborn St Gaithersburg, MD 20878.
EXCLUSIVE LICENSE AGREEMENTLicense Agreement • November 10th, 2014 • Cohbar, Inc. • Pharmaceutical preparations • California
This Exclusive License Agreement and the attached Appendices A, B and C (collectively, the “Agreement”) is made and is effective this 6th day of August 2013 (the “Effective Date”) between THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (“The Regents”), a California corporation having its corporate offices located at 1111 Franklin Street, Oakland, California 94607-5200, acting through The Office of Intellectual Property and Industry Sponsored Research of the University of California, Los Angeles, located at 11000 Kinross Avenue, Suite 200, Los Angeles, CA 90095-1406 and COHBAR, INC. (“Licensee”), a Delaware corporation having a principal place of business at 2265 E. Foothill Blvd., Pasadena, California 91107.
CONSULTING AGREEMENTConsulting Agreement • November 10th, 2014 • Cohbar, Inc. • Pharmaceutical preparations • California
THIS CONSULTING AGREEMENT (the “Agreement”) is made as of the 29th day of September, 2014 (the “Effective Date”), by and between Dr. Pinchas Cohen, an individual residing at 16577 Chattanooga Place, Pacific Palisades, CA 90272 (the “Consultant”), and COHBAR, INC., a Delaware corporation with its principal place of business at 2265 East Foothill Blvd., Pasadena, CA 91107 (the “Company”). In consideration of the promises contained herein and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:
EXTENSION AGREEMENTExtension Agreement • November 10th, 2014 • Cohbar, Inc. • Pharmaceutical preparations • New York
This Extension Agreement (the “Agreement”), effective this 1st day of November, 2014, is made by and between Nir Barzilai (the “Consultant”) and CohBar, Inc., a Delaware corporation (the “Company”).
